Understanding the precise molecular mechanisms through which PTH affects skeletal muscle could lead to new therapeutic approaches for preventing and treating skeletal muscle-related disorders, particularly in conditions such as hyperparathyroidism, chronic kidney disease, and age-related muscle loss. This evidence concerns the gene PTH and chronic kidney disease.